Unichem Laboratories Ltd. — Interim / Quarterly Report 2020

Jul 9, 2020

==> picture [190 x 43] intentionally omitted <==

July 9, 2020

Department of Corporate Services Mr. Hari K

Bombay Stock Exchange Ltd. Asst. Vice President - Operations Phiroze Jeejeebhoy Towers National Stock Exchange of India Ltd Dalal Street, Exchange Plaza, Bandra – Kurla Complex Mumbai- 400 001 Bandra (East), Mumbai – 400 051

Dear Sir,

Ref: BSE Scrip Code -506690: NSE Symbol – UNICHEMLAB

Sub: Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India {Listing Obligations and Disclosure Requirements} Regulations, 2015 ("Listing Regulations")

Dear Sir/Madam,

Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed the disclosure of Related Party Transactions on a consolidated basis for half year ended March 31, 2020 drawn in accordance with the applicable Accounting Standards.

Kindly take the same on your records.

Thanking you,

FOR UNICHEM LABORATORIES LIMITED

PRADEEP Digitally signed by PRADEEP BHANDARI BHANDARI Date: 2020.07.09 09:50:44 +05'30'

PRADEEP BHANDARI Head- Legal & Company Secretary

Encl: a/a

==> picture [189 x 32] intentionally omitted <==

Registered Office: Unichem Bhavan, Prabhat Estate, Off S. V. Road Jogeshwari (West), Mumbai – 400 102, Maharashtra, India.

UNICHEM LABORATORIES LIMITED Disclosure of related party transactions for the half year ended 31st March, 2020 RELATED PARTY DISCLOSURES

Disclosure of related parties / related party transactions pursuant to Ind AS 24 "Related Party Disclosure".

a) List of related parties

(i) Enterprises under significant influence of

List of relatedparties	List of relatedparties
(i) Enterprises under significant influence of
Uni - Distributors Pvt. Ltd. Elemage Wellness LLP Adiwasi Unnati Mandal Uni Trust Also Refer note (f) key management personnel as defined in (ii)
(ii) Key management personnel and their relatives: (disclosed to the extent of transactions) Mrs Anita Mody (Spouse of CMD) Ms Supriya Mody (Daughter of CMD) Ms. Suparna Mody (Daughter of CMD) Ms. Shwetambari Mody (Daughter of CMD) Mr. Dilip J. Kunkolienkar (Director - Technical) Dr. Prakash A. Mody (Chairman & Managing Director - CMD,Promoter)	(iii) Independent Directors: Dr. (Mrs.) B. Kinnera Murthy Mr. Anand Y. Mahajan Mr. Prafull Anubhai Mr. Prafull D Sheth
(iv) Post-employment benefit plans: Unichem Laboratories Ltd- Employees Gratuity Fund Unichem Laboratories Ltd- Employees Superannuation Fund	(v) Key management personnel and their: relatives as per Companies Act, 2013. Mr. Pradeep Bhandari- (Head- Legal & Company Secretary) (w.e.f. 01.08. 2019) Mrs. Neema Thakore (Head - Legal & Company Secretary) (upto 31.07.2019) Mr. Sandip Ghume (Dy. Chief Financial Officer)

b) Disclosure of related party transactions :

(Rs. in lakhs)

Disclosure of related party transactions :	(Rs. in lakhs)
Particulars	Half year ended 31st March 2020
i) Rent & Maintenance Paid (excluding indirect taxes) Relative of Key Management Personnel Mrs Anita Mody Enterprise under significant influence of Key Management Personnel Uni - Distributors Pvt. Ltd. Uni Trust ii) Managerial remuneration ( including defined contribution plan) Key Management Personnel Dr. Prakash A. Mody Mr. Dilip J Kunkolienkar iii) Salary ( including defined contribution plan) Relative of Key Management Personnel Ms Supriya Mody iv) Sitting Fees Independent Directors Dr. (Mrs.) B. Kinnera Murthy Mr. Anand Y. Mahajan Mr. Prafull Anubhai Mr. Prafull D Sheth	9.35 6.82 4.50
	20.67
	306.13 69.36
	375.49
	40.16
	40.16
	6.50 5.00 7.00 5.00
	23.50

c) Disclosure of related party balances :

(Rs. in lakhs)

Disclosure of related party balances :	23.50 (Rs. in lakhs)
Particulars	Half year ended 31st March 2020
i.) Deposits paid Relative of Key Management Personnel Mrs Anita Mody Enterprise under significant influence of Key Management Personnel Uni - Distributors Pvt. Ltd. Uni Trust ii.) Other Current Liabilities Key Management Personnel Dr. Prakash A. Mody	45.90 5.00 2.25
	53.15
	33.67
	33.67

==> picture [102 x 31] intentionally omitted <==

PRADEEP Digitally signed by PRADEEP BHANDARI BHANDARI Date: 2020.07.09 09:51:46 +05'30'

d) Contribution to post employment benefit plan :

(Rs. in lakhs)

Contribution to post employment benefit plan :	(Rs. in lakhs)
Particulars	Half year ended 31st March 2020
Post-employment benefit plans Unichem Laboratories Ltd- Employees Gratuity Fund Unichem Laboratories Ltd- Employees Superannuation Fund	10.61 41.09
	51.70

e) Following are Key management Personnel (not covered above) in accordance with provisions of the Indian Companies Act, 2013. Details of transactions and balances are below :

Following are Key management Personnel (not covered above) in accordance with provisions of the transactions and balances are below :	Indian Companies Act, 2013. Details of
	(Rs. in Lakhs)
Particulars	Half year ended 31st March 2020
i.) Salary ( including defined contribution plan) Key Management Personnel Mrs. Neema Thakore Mr. Pradeep Bhandari Mr. Sandip Ghume	0.08 35.00 22.29
	57.37

• 1 Number of options pending to be exercised by Mr. Dilip Kunkolienkar as on 31st March, 2020 are 2,46,176.

• 2 Key Managerial Personnel and their Relatives who are under the employment of the Company are entitled to post employment benefits and other long term employee benefits recognised as per Ind AS 19 - ‘Employee Benefits’ in the financial statements. As these employee benefits are lump sum amounts provided on the basis of actuarial valuation, the same is not included above. Further, it also does not include actual payments of gratuity and leave encashment. Also, re-imbursement of expenses to KMP and their relatives are not included above.

• 3 Related party contracts / arrangements have been entered in ordinary course of business and are approved by the board of directors/ shareholders as applicable.

• f) In view of the Management , equity Investment in Synchron Research Services Pvt Ltd will not result the investee company becoming a related party since there is no control / influence over operations :

The summary of transactions with Synchron Research Services Pvt. Ltd are as follows:

w of the Management , equity Investment in Synchron Research Services Pvt Ltd will not result the investee company becoming a related party since is no control / influence over operations : ummary of transactions with Synchron Research Services Pvt. Ltd are as follows:	w of the Management , equity Investment in Synchron Research Services Pvt Ltd will not result the investee company becoming a related party since is no control / influence over operations : ummary of transactions with Synchron Research Services Pvt. Ltd are as follows:
(Rs. in Lakhs)
Particulars	Half year ended 31st March 2020
Research & Development Expenditure (Bio-equivalence studies) Rent Income ( net of indirect tax) Deposit received	4.30 22.32 7.50

PRADEEP Digitally signed by PRADEEP BHANDARI BHANDARI Date: 2020.07.09 09:55:38 +05'30'

==> picture [102 x 31] intentionally omitted <==